Which trial do we need? Plasma metagenomic next-generation sequencing to diagnose infections in patients with haematological malignancies and febrile neutropenia: proposal for a randomized-controlled trial Editorial

  

Authors:	Hogan, C. A.; Miller, S.; Piantadosi, A.; Gaston, D. C.; Simner, P. J.; Nash, S.; Babady, N. E.
Title:	Which trial do we need? Plasma metagenomic next-generation sequencing to diagnose infections in patients with haematological malignancies and febrile neutropenia: proposal for a randomized-controlled trial
Keywords:	controlled study; randomized controlled trial; febrile neutropenia; hematologic neoplasms; microbiology; hematologic disease; complication; metagenome; diagnostics; high throughput sequencing; high-throughput nucleotide sequencing; immunocompromised; next-generation sequencing; metagenomics; humans; human; infectious diseases; clinical metagenomics; haematological malignancy
Journal Title:	Clinical Microbiology and Infection
Volume:	29
Issue:	12
ISSN:	1198-743X
Publisher:	Elsevier Inc.
Date Published:	2023-12-01
Start Page:	1474
End Page:	1479
Language:	English
DOI:	10.1016/j.cmi.2023.05.024
PUBMED:	37244468
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85163339556&doi=10.1016%2fj.cmi.2023.05.024&partnerID=40&md5=f30425bea36bd112b6f96ac5370da30c
Notes:	Note -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/212345